Tamoxifen therapy benefit predictive signature combining with prognostic signature in surgical‐only ER‐positive breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tamoxifen therapy benefit predictive signature combining with prognostic signature in surgical‐only ER‐positive breast cancer

Published:2018-12-07 Issue:7 Volume:234 Page:11140-11148
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Lv Feng¹^ORCID,Jin Wei‐Hua²,Zhang Xian‐Lin¹,Wang Zhong‐Rui³,Sun Ai‐Jun⁴^ORCID

Affiliation:

1. Department of General Surgery Affiliated Renhe Hospital of China Three Gorges University Yichang Hubei China

2. Hubei Three Gorges Polytechnic Yichang Hubei China

3. Department of General Surgery Shanghai East Hospital, Tongji University School of Medicine Shanghai China

4. Department of General Surgery Huai'an Second People's Hospital, The Affiliated Huai'an Hospital of Xuzhou Medical University Huai'an China

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.27756

Reference37 articles.

1. Breast cancer is the most common cause of cancer death in women;Adams K.;Lamp,1997

2. Estrogen receptors as therapeutic targets in breast cancer;Ariazi E.;Current Topics in Medicinal Chemistry,2006

3. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

4. Silencing diacylglycerol kinase-theta expression reduces steroid hormone biosynthesis and cholesterol metabolism in human adrenocortical cells

5. Live Animal Markets in Minnesota: A Potential Source for Emergence of Novel Influenza A Viruses and Interspecies Transmission

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of BMPR2 in the Development and Progression of Osteoporosis: An Experimental Study in Mice;2023-04-04

2.

¹⁸F-FHBG PET-CT Reporter Gene Imaging of Adoptive CIK Cell Transfer Immunotherapy for Breast Cancer in a Mouse Model

;OncoTargets and Therapy;2020-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3